Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with higher baseline serum levels of IgE and TARC but not clinical severity in a real-world setting

Conjunctivitis in patients with atopic dermatitis treated with dupilumab is associated with baseline serum levels of IgE and TARC but not subjective severity scores in a real-world setting. These objective parameters are useful as practical predictors of later development of conjunctivitis.

Source: Journal of the American Academy of Dermatology - December 25, 2019 Category: Dermatology Authors: Hideaki Uchida, Masahiro Kamata, Mayumi Nagata, Saki Fukaya, Kotaro Hayashi, Atsuko Fukuyasu, Takamitsu Tanaka, Takeko Ishikawa, Takamitsu Ohnishi, Yayoi Tada Source Type: research